Our vision is to grow and diversify our parent company, Envirosafe Chemicals Canada to expand our offering with Curativa Cannabis, as a division of Envirosafe Chemicals Canada, by diversifying into the medical marijuana industry, to increase our revenue and offer a significant return for our investors.

​

• Our goal is to cultivate and produce high-quality, clean cannabis products for medicinal use. ​We will provide commercial-scale cannabis with an unmatched level of environmental control, to develop, refine, and repeat specific growth conditions.

​​

• With historical industrial production experience, and significant knowledge of marijuana production, we aim to be a leader in the cannabis industry and evolve with the needs of our consumers.

 

• Our controlled growth strategy for our production facility with potential annual revenues of $15M for 10,000 grams per annum produced the first year, with increased growth potential annual revenues thereafter to $42M for 28,000 grams per annum produced.

​

• Fortunes will be made as international medical cannabis markets balloon to $142B+ over the next 15 years. The Canadian market is HERE and NOW, with growing acceptance, increasing evidence of effectiveness, and political environment favourable for legislation.

​​

• To maximize profits in this space, investors should have direct exposure to licensed Canadian medical cannabis producers.

​

• Opportunity for investment in Canada, in particular Saskatchewan and northern Canada is nearly untapped, and nationally medical marijuana production as current supply cannot meet demand.

​​

• If legislation in Canada legalizes recreational marijuana use, we will be prepared to expand into the same.